Equities
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)1,850.00
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 01 2020.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income6,7176,5525,893
Depreciation/depletion4,0713,4173,398
Non-Cash items(560)1,6831,617
Cash taxes paid, supplemental3,4002,4001,900
Cash interest paid, supplemental2,4001,2001,200
Changes in working capital(484)(733)(1194)
Total cash from operations8,4719,7219,261
INVESTING
Capital expenditures(1112)(936)(880)
Other investing and cash flow items, total(25092)(5108)1,613
Total cash from investing(26204)(6044)733
FINANCING
Financing cash flow items(72)(103)(78)
Total cash dividends paid(4556)(4196)(4013)
Issuance (retirement) of stock, net0(6360)(4975)
Issuance (retirement) of debt, net25,6766,622795
Total cash from financing21,048(4037)(8271)
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash3,315(360)1,723
Net cash-begin balance/reserved for future use7,6297,9896,266
Net cash-end balance/reserved for future use10,9447,6297,989
SUPPLEMENTAL INCOME
Depreciation, supplemental4,0713,4173,398
Cash interest paid, supplemental2,4001,2001,200
Cash taxes paid, supplemental3,4002,4001,900
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.